Boston Scientific Corporation (BSX) 2025 Investor Day Call Transcript

Company Participants

Lauren Tengler – Director of Investor Relations
Michael Mahoney – Chairman, President & CEO
Arthur Butcher – Executive VP and Group President of MedSurg & Asia Pacific
Jim Cassidy
Meghan Scanlon
Adam Smith
Brian Dunkin
Joseph Fitzgerald – Executive VP & Group President of Cardiology
Peter Pattison – President of the Interventional Oncology Division
Catherine Jennings
Lance Bates
Janarthanan Sathananthan – Chief Medical Officer of Interventional Cardiology Therapies
Scott Olson
Ken Stein – Senior VP & Global Chief Medical Officer
Angelo De Rosa
Brad Sutton
Nicholas Spadea-Anello
Jonathan Monson – Executive VP & CFO

Conference Call Participants

Joanne Wuensch – Citigroup Inc., Research Division
Frederick Wise – Stifel, Nicolaus & Company, Incorporated, Research Division
David Rescott – Robert W. Baird & Co. Incorporated, Research Division
Jayson Bedford – Raymond James & Associates, Inc., Research Division
Pito Chickering – Deutsche Bank AG, Research Division
Travis Steed – BofA Securities, Research Division
Matthew Miksic – Barclays Bank PLC, Research Division
Larry Biegelsen – Wells Fargo Securities, LLC, Research Division
Danielle Antalffy – UBS Investment Bank, Research Division
Robert Marcus – JPMorgan Chase & Co, Research Division
Anthony Petrone – Mizuho Securities USA LLC, Research Division
Michael Polark – Wolfe Research, LLC
Joshua Jennings – TD Cowen, Research Division
Vijay Kumar – Evercore ISI Institutional Equities, Research Division
Michael Matson – Needham & Company, LLC, Research Division
Marie Thibault – BTIG, LLC, Research Division
Matthew Taylor – Jefferies LLC, Research Division
David Roman – Goldman Sachs Group, Inc., Research Division
Richard Newitter – Truist Securities, Inc., Research Division
Matthew O’Brien – Piper Sandler & Co., Research Division

Conversation